Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model
العنوان: | Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model |
---|---|
المؤلفون: | Hyunsu Bae, Y.-N. Yim, Min Kyu Shin, Yangseok Kim, Moo Chang Hong, Youngseop Lee, Namhee Park, Dong-Won Kim, Chongwoon Cho, Eunjung Ko, Jin Cheon Kim |
المصدر: | Lupus. 16:335-341 |
بيانات النشر: | SAGE Publications, 2007. |
سنة النشر: | 2007 |
مصطلحات موضوعية: | medicine.medical_specialty, Lymphocyte, Population, Autoimmunity, 030204 cardiovascular system & hematology, Kidney, Interferon-gamma, Mice, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Interferon, Oral administration, Internal medicine, Splenocyte, medicine, Animals, Lupus Erythematosus, Systemic, skin and connective tissue diseases, education, Chromatography, High Pressure Liquid, 030203 arthritis & rheumatology, education.field_of_study, Proteinuria, Mice, Inbred NZB, biology, business.industry, Antibody titer, Blood Cell Count, Disease Models, Animal, Endocrinology, medicine.anatomical_structure, Antibodies, Antinuclear, Immunology, biology.protein, Female, Interleukin-4, medicine.symptom, Antibody, business, Spleen, Drugs, Chinese Herbal, medicine.drug |
الوصف: | The immunosuppressive effects of Sophorae radix (SR) make this plant an attractive agent for the treatment of autoimmune diseases. The effect of SR on systemic lupus erythematosus (SLE) in the New Zealand Black/White F1(NZB/w F1) mouse model system was investigated. Three-month-old NZB/w F1mice were separated into two groups: one treated with SR (1% SR solution by oral administration, daily for 15 weeks) and one with water as a control. Experimental parameters include proteinuria, anti-dsDNA antibody titers, T-cell response and renal histopathological analysis. Results in the SR-treated group showed a significant reduction in proteinuria and anti-dsDNA antibodies either in serum or in glomerular capillaries, along with significant recovery from renal glomerular damage. The lymphocyte population was significantly increased in the SR-treated mice compared with the control group. In the T helper (Th)1/Th2 cytokine secretion profile, interferon-γ in splenocyte culture was significantly reduced in the SR-treated mice, while interleukin-4 secretion was not altered. These results strongly suggest SR therapy corrects the deviated Th1/Th2 balance, thereby alleviating SLE-like symptoms in the NZB/w F1mice. Therefore, SR may be useful in the clinical treatment of SLE. Lupus (2007) 16, 335—341. |
تدمد: | 1477-0962 0961-2033 |
DOI: | 10.1177/0961203307078228 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02286aaa06dac4d6793c27a725e00fea https://doi.org/10.1177/0961203307078228 |
Rights: | CLOSED |
رقم الانضمام: | edsair.doi.dedup.....02286aaa06dac4d6793c27a725e00fea |
قاعدة البيانات: | OpenAIRE |
تدمد: | 14770962 09612033 |
---|---|
DOI: | 10.1177/0961203307078228 |